Agenus | AGEN - 税前利润





税前利润 更改 日
AbbVie USD 7.61B 2.04B 2026-06
Agenus USD -10.61M 263.52M 2025-12
Amgen USD 1.51B 2.41B 2025-12
AstraZeneca USD 4.81B 894M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Celldex Therapeutics USD -81.32M 14.27M 2025-12
CSL USD 2.61B 1.21B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
Glaxosmithkline GBP 2.14B 312M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Intrexon USD -60.48M 27.09M 2024-06
J&J USD 8.66B 839M 2026-06
Jiangsu Hengrui CNY 2.56B 261.24M 2026-03
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
MacroGenics USD -36.77M 21.84M 2026-03
Merck EUR 401M 886.1M 2025-12
Merck USD 3.42B 3.32B 2025-12
Novartis USD 4.27B 430M 2026-06
Novavax USD 17.9M 220.94M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Veracyte USD 26.52M 3.45M 2026-06